Skip to main content
Neoplasia (New York, N.Y.) logoLink to Neoplasia (New York, N.Y.)
. 2024 Sep 28;57:101064. doi: 10.1016/j.neo.2024.101064

Corrigendum to “Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment” [Neoplasia, Volume 22, Issue 2 (2020) 111–119]

Steven Kregel a,b,c, Chao Wang d, Xin Han d, Lanbo Xiao a,b,c, Ester Fernandez-Salas a,c,d, Pushpinder Bawa a,b,c, Brooke L McCollum a, Kari Wilder-Romans e, Ingrid J Apel a,b,c, Xuhong Cao a,c,g, Corey Speers c,d, Shaomeng Wang a,c,d, Arul M Chinnaiyan a,b,c,f,g,
PMCID: PMC11736330  PMID: 39389678

The authors regret accidental duplications that occurred in Figure 4b of this manuscript. The corrected Figure 4 is shown below.

This error does not affect the interpretation of the data in the manuscript, but the authors would like to apologize for any inconvenience caused.

Figure 4

Unlabelled image


Articles from Neoplasia (New York, N.Y.) are provided here courtesy of Neoplasia Press

RESOURCES